Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices (Q37694529)

22 August 2017

1 reference

title

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices (English)

1 reference

22 August 2017

1 reference

0 references

Johann D D Pitout

1

1 reference

22 August 2017

1 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

70

1 reference

22 August 2017

313-333

1 reference

22 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/11533040-000000000-00000

22 August 2017

0 references

cites work

Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11533040-000000000-00000

Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11533040-000000000-00000

In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11533040-000000000-00000

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study

21 January 2018

1 reference

12 December 2020

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

1 reference

12 December 2020

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

1 reference

12 December 2020

Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum β-lactamase-producing organisms in an intensive care unit

1 reference

12 December 2020

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

12 December 2020

blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures

1 reference

12 December 2020

Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

1 reference

12 December 2020

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

1 reference

12 December 2020

The CTX-M beta-lactamase pandemic.

1 reference

12 December 2020

Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000).

1 reference

12 December 2020

In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study

1 reference

12 December 2020

In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli

1 reference

12 December 2020

Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin

1 reference

12 December 2020

UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone

1 reference

12 December 2020

Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection

1 reference

12 December 2020

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isola

1 reference

12 December 2020

Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.

1 reference

12 December 2020

Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.

1 reference

12 December 2020

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

1 reference

12 December 2020

Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

1 reference

12 December 2020

Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru.

1 reference

12 December 2020

Addressing the challenge of extended-spectrum beta-lactamases.

1 reference

12 December 2020

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

12 December 2020

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

12 December 2020

ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli

1 reference

12 December 2020

Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum- -lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate

1 reference

12 December 2020

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

1 reference

12 December 2020

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

1 reference

12 December 2020

Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.

1 reference

12 December 2020

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

1 reference

12 December 2020

Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal

1 reference

12 December 2020

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.

1 reference

12 December 2020

Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids.

1 reference

12 December 2020

Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004

1 reference

12 December 2020

Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline

1 reference

12 December 2020

Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand

1 reference

12 December 2020

Extended-spectrum beta-lactamases: a clinical update

1 reference

12 December 2020

Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals

1 reference

12 December 2020

Extended-spectrum beta-lactamases (ESBL) in community isolates from North India: frequency and predisposing factors

1 reference

12 December 2020

Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals

1 reference

12 December 2020

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

12 December 2020

Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam

1 reference

12 December 2020

Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).

1 reference

12 December 2020

Genetic support of extended-spectrum beta-lactamases

1 reference

12 December 2020

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.

1 reference

12 December 2020

Resistance plasmid families in Enterobacteriaceae

1 reference

12 December 2020

Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France

1 reference

12 December 2020

Multiresistant Enterobacteriaceae: new threat of an old problem

1 reference

12 December 2020

Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006.

1 reference

12 December 2020

Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species

1 reference

12 December 2020

European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis

1 reference

12 December 2020

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

12 December 2020

Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread

1 reference

12 December 2020

Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.

1 reference

12 December 2020

Dominance of blaCTX-M within an Australian extended-spectrum beta-lactamase gene pool

1 reference

12 December 2020

Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria

1 reference

12 December 2020

Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study

1 reference

12 December 2020

Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region

1 reference

12 December 2020

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

1 reference

12 December 2020

Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community

1 reference

12 December 2020

Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.

1 reference

12 December 2020

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

12 December 2020

Emergence of imipenem resistance in clinical Escherichia coli during therapy

1 reference

12 December 2020

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime

1 reference

12 December 2020

Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates

1 reference

12 December 2020

Prevalence of extended-spectrum beta-lactamases in South America

1 reference

12 December 2020

Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates

1 reference

12 December 2020

Extended-spectrum beta-lactamases in long-term-care facilities

1 reference

12 December 2020

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

12 December 2020

Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

1 reference

12 December 2020

Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital

1 reference

12 December 2020

Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon

1 reference

12 December 2020

Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15.

1 reference

12 December 2020

Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui

1 reference

12 December 2020

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline

1 reference

12 December 2020

CTX-M: changing the face of ESBLs in Europe

1 reference

12 December 2020

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

12 December 2020

The new beta-lactamases.

1 reference

12 December 2020

High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania

1 reference

12 December 2020

Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection

1 reference

12 December 2020

First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system

1 reference

12 December 2020

Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions

1 reference

12 December 2020

Clinical and economic burden of antimicrobial resistance.

1 reference

12 December 2020

Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe

1 reference

12 December 2020

Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections

1 reference

12 December 2020

Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.

1 reference

12 December 2020

Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective

1 reference

12 December 2020

Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France

1 reference

12 December 2020

Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel

1 reference

12 December 2020

Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1.

1 reference

12 December 2020

Spinal infection caused by ESBL-producing Klebsiella pneumoniae treated with temocillin

1 reference

12 December 2020

Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases

1 reference

12 December 2020

Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element

1 reference

12 December 2020

Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae

1 reference

12 December 2020

Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases.

1 reference

12 December 2020

Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum beta-lactamase

1 reference

12 December 2020

Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five US States

1 reference

12 December 2020

Gram-negative antibiotic resistance: there is a price to pay.

1 reference

12 December 2020

CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem

1 reference

12 December 2020

Multilocus sequence typing: Data analysis in clinical microbiology and public health

1 reference

12 December 2020

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

12 December 2020

Prevalence and clonality of extended-spectrum beta-lactamases in Asia

1 reference

12 December 2020

Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes

1 reference

12 December 2020

Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene

1 reference

12 December 2020

The spread of CTX-M-type extended-spectrum beta-lactamases.

1 reference

12 December 2020

In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units

1 reference

12 December 2020

Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada

1 reference

12 December 2020

Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli.

1 reference

12 December 2020

Detection of CTX-M-1, CTX-M-15, and CTX-M-2 in clinical isolates of Enterobacteriaceae in Bogota, Colombia

1 reference

12 December 2020

Early dissemination of CTX-M-derived enzymes in South America

1 reference

12 December 2020

1 reference

12 December 2020

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae

1 reference

12 December 2020

Extended-spectrum beta-lactamases in North America, 1987-2006.

1 reference

12 December 2020

[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].

1 reference

12 December 2020

Dissemination of CTX-M-15 beta-lactamase genes carried on Inc FI and FII plasmids among clinical isolates of Escherichia coli in a university hospital in Istanbul, Turkey

1 reference

12 December 2020

Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting

1 reference

12 December 2020

Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates

1 reference

12 December 2020

Characterization of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from hospital environments in Algeria

1 reference

12 December 2020

Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam

1 reference

12 December 2020

Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.

1 reference

12 December 2020

Extended-spectrum beta-lactamases and clinical outcomes: current data

1 reference

12 December 2020

Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.

1 reference

12 December 2020

Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

12 December 2020

Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system.

1 reference

12 December 2020

Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway

1 reference

12 December 2020

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study

1 reference

12 December 2020

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline

1 reference

12 December 2020

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

1 reference

12 December 2020

10.2165/11533040-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20166768

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

20166768